Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Cancer

• Publication date

  2006-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.21821PMID 16470838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

  2005influential reference
• End-to-end communication in the modulation of translation by mammalian RNA viruses

  2005cited by this paper
• Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

  2005cited by this paper
• VSV-tumor selective replication and protein translation

  2005cited by this paper
• To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control

  2005cited by this paper
• Cell type-specific involvement of RIG-I in antiviral response.

  2005influential reference
• Not all viruses are bad guys: the case for reovirus in cancer therapy.

  2005cited by this paper
• The structure of the flock house virus B2 protein, a viral suppressor of RNA interference, shows a novel mode of double‐stranded RNA recognition

  2005cited by this paper
• Viruses know it all: new insights into IFN networks.

  2005cited by this paper
• Oncolytic virotherapy for cancer treatment: challenges and solutions

  2005cited by this paper
• Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA

  2004cited by this paper
• Antitumor Vaccination in Patients with Head and Neck Squamous Cell Carcinomas with Autologous Virus-Modified Tumor Cells

  2004cited by this paper
• High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules.

  2004cited by this paper
• Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.

  2004cited by this paper
• Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.

  2004cited by this paper
• The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.

  2004cited by this paper
• Weapons of STAT destruction

  2004cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein.

  2004cited by this paper
• Missorting of LaCrosse Virus Nucleocapsid Protein by the Interferon‐Induced MxA GTPase Involves Smooth ER Membranes

  2004cited by this paper
• Defective translational control facilitates vesicular stomatitis virus oncolysis.

  2004cited by this paper
• Vesicular Stomatitis: an Oncolytic Virus that Exploits Tumor-Specific Defects in the Interferon Pathway

  2004cited by this paper
• Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNA.

  2003cited by this paper
• TNF-Related Apoptosis-Inducing Ligand Mediates Tumoricidal Activity of Human Monocytes Stimulated by Newcastle Disease Virus 1

  2003cited by this paper
• Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

  2003cited by this paper
• Development of Recombinant Vesicular Stomatitis Viruses That Exploit Defects in Host Defense To Augment Specific Oncolytic Activity

  2003cited by this paper
• Self-assembly of Human MxA GTPase into Highly Ordered Dynamin-like Oligomers*

  2002influential reference
• Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis.

  2002cited by this paper
• Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer

  2002cited by this paper
• Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.

  2002cited by this paper
• The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors.

  2002cited by this paper
• RNA viruses as virotherapy agents

  2002cited by this paper
• Reovirus therapy of lymphoid malignancies.

  2002cited by this paper
• Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients.

  2002cited by this paper
• The role of chemokines in linking innate and adaptive immunity.

  2002cited by this paper
• Interferon‐Induced Mx Proteins: Dynamin‐Like GTPases with Antiviral Activity

  2002cited by this paper
• The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

  2002cited by this paper
• Links between innate and adaptive immunity via type I interferon.

  2002cited by this paper
• Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice.

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1

  2001cited by this paper
• Replication-Competent, Oncolytic Newcastle Disease Virus for Cancer Therapy

  2001influential reference
• Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction

  2000cited by this paper
• Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection.

  2000cited by this paper
• Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

  2000cited by this paper
• Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

  2000cited by this paper
• Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

  2000cited by this paper
• Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

  1999cited by this paper
• The Human 2',5'-Oligoadenylate Synthetase Family: Interferon-Induced Proteins with Unique Enzymatic Properties

  1999influential reference
• Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells.

  1999cited by this paper
• How cells respond to interferons.

  1998cited by this paper
• The Double-Stranded RNA-Dependent Protein Kinase PKR: Structure and Function

  1997cited by this paper
• Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.

  1997cited by this paper
• Tumor-Cell Number and Viability as Quality and Efficacy Parameters of Autologous Virus-Modified Cancer Vaccines in Patients With Breast or Ovarian Cancer

  1997cited by this paper
• Viral infection.

  1996cited by this paper
• Treatment of human cancer with mumps virus

  1974cited by this paper
• Mumps virus.

  1947cited by this paper

• Development of an apoptotic lentogenic Newcastle disease virus strain by incorporating the p30 protein of African swine fever virus.

  2025cites this paper
• Oncolytic mechanisms and immunotherapeutic potential of Newcastle disease virus in cancer therapy

  2025cites this paper
• Evaluation of Apoptosis and Cytotoxicity Induction Using a Recombinant Newcastle Disease Virus Expressing Human IFN-γ in Human Prostate Cancer Cells In Vitro

  2025cites this paper
• Research progress on recombinant NDV in cancer therapy

  2025cites this paper
• Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy

  2025cites this paper
• Ferroptosis, from the virus point of view: opportunities and challenges

  2024cites this paper
• The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy

  2024cites this paper
• Progress of Oncolytic Virus

  2024cites this paper
• Genome-wide CRISPR screen reveals specific role of type I interferon signaling pathway in Newcastle disease virus establishment of persistent infection.

  2024cites this paper
• Chimeric Newcastle Disease Virus Vectors Expressing Human IFN-γ Mediate Target Immune Responses and Enable Multifaceted Treatments

  2023cites this paper
• Antiproliferative effects of mesenchymal stem cells carrying Newcastle disease virus and Lactobacillus Casei extract on CT26 Cell line: synergistic effects in cancer therapy

  2023cites this paper
• DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus

  2023cites this paper
• Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma

  2023cites this paper
• Recombinant Newcastle disease virus kills liver cancer in vitro and in vivo

  2023cites this paper
• Gospel of malignant Glioma: Oncolytic virus therapy.

  2022cites this paper
• Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus

  2022influential citation
• Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus

  2022cites this paper
• Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical

  2022cites this paper
• In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review

  2022cites this paper
• Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy

  2022cites this paper
• Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling

  2021cites this paper
• Oncolytic viruses: A novel treatment strategy for breast cancer

  2021cites this paper
• Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes

  2021cites this paper
• Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models

  2021cites this paper
• Viral Proteins as Emerging Cancer Therapeutics

  2021cites this paper
• Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?

  2021influential citation
• Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells

  2021cites this paper
• Rapid Generation of a Recombinant Genotype VIII Newcastle Disease Virus (NDV) Using Full-Length Synthetic cDNA

  2021cites this paper
• Recent advances of oncolytic virus in cancer therapy

  2020cites this paper
• Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells

  2020cites this paper
• Newcastle Disease Virus at the Forefront of Cancer Immunotherapy

  2020cites this paper
• Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses

  2020cites this paper
• Different kinetics of chicken interferon-alpha signalling transduction responses following immunization of broiler chickens with different Newcastle disease virus vaccines and infection with virulent genotype VIId strain

  2020cites this paper
• Oncolytic Viruses as Immunotherapeutic Agents

  2020cites this paper
• Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells.

  2020cites this paper
• Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification

  2020cites this paper
• Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion

  2020cites this paper
• RETRACTED ARTICLE: Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses

  2020cites this paper
• Clinical, molecular and cytopathological characterization of a Newcastle disease virus from an outbreak in Baghdad, Iraq

  2020cites this paper
• Evaluation of Newcastle disease virus mediated dendritic cell activation and cross‐priming tumor‐specific immune responses ex vivo

  2019cites this paper
• Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

  2019influential citation
• Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5

  2019cites this paper
• Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of β-catenin and matrix metalloproteinase-7

  2019cites this paper
• Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus

  2019cites this paper
• Caspase Dependent and Independent Anti-hematological Malignancy Activity of AMHA1 Attenuated Newcastle Disease Virus

  2019cites this paper
• Clinical Trial Outcomes: What Matters to Patients.

  2019cites this paper
• Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma

  2019cites this paper
• Utilizing Microbes to Treat Naturally Occurring Cancer in Veterinary Species

  2019cites this paper
• Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis

  2019cites this paper
• Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies

  2018cites this paper
• Newcastle disease virus strain AF2240 as an oncolytic virus: A review.

  2018cites this paper
• Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer

  2018cites this paper
• PVSRIPO Effect on Cancer

  2018cites this paper
• Regulation of Constitutive Interferon-Stimulated Genes (Isgs) in Tumor Cells Contributes to Enhanced Antitumor Response of Newcastle Disease Virus-Infected Tumor Vaccines

  2018cites this paper
• Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro

  2018cites this paper
• The advent of oncolytic virotherapy in oncology: The Rigvir® story

  2018cites this paper
• METHOD FOR CANCER IMMUNOTHERAPY AND PHARMACEUTICAL COMPOSITIONS BASED ON ONCOLYTIC NON-PATHOGENC SENDAVIRUS FIELD OF THE INVENTION

  2017cites this paper
• Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy

  2017cites this paper
• Newcastle disease virus induces stable formation of bona fide stress granules to facilitate viral replication through manipulating host protein translation

  2017cites this paper
• Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer

  2017cites this paper
• Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach

  2017cites this paper
• Virotherapy with Newcastle Disease Virus for Cancer Treatment and its Efficacy in Clinical Trials

  2017cites this paper
• Immunobiology of Anticancer Virotherapy With Newcastle Disease Virus in Cancer Patients

  2017cites this paper
• Proinflammatory response induced by Newcastle disease virus in tumor and normal cells

  2017cites this paper
• Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

  2017cites this paper
• Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity

  2017cites this paper
• Development of oncolytic virotherapy for the treatment of oral cancer – At the waiting stage for clinical use

  2017cites this paper
• The Role of Type-I Interferon in Limiting Spread and Killing of an Oncolytic RNA Virus in Prostate Cells

  2016cites this paper
• N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells

  2016cites this paper
• Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists

  2016cites this paper
• Improving the Delivery and Replication of Oncolytic Viruses

  2016cites this paper
• Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!

  2016cites this paper
• Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy

  2016cites this paper
• Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway

  2015cites this paper
• Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors

  2015cites this paper
• Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma

  2015cites this paper
• Signaling through RIG-I and type I interferon receptor: Immune activation by Newcastle disease virus in man versus immune evasion by Ebola virus (Review).

  2015cites this paper
• Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice

  2015cites this paper
• Oncolysis by paramyxoviruses: preclinical and clinical studies

  2015cites this paper
• Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations

  2015cites this paper
• Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.

  2015cites this paper
• Durchbrechen von Therapieresistenzen

  2015cites this paper
• Oncolytic Newcastle Disease Virus as treatment for pancreatic cancer

  2015influential citation
• Viruses: Promising Anti-Oncogenic Virotherapy

  2015cites this paper
• Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

  2015cites this paper
• Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells in vivo

  2014cites this paper
• ISG12a mediates cell response to Newcastle disease viral infection.

  2014cites this paper
• Non-Specific Immunostimulatory Capacity of Newcastle Disease Virus (NDV) and Suppression of Breast Cancer Cells

  2014cites this paper
• Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection

  2014cites this paper
• Apoptins: selective anticancer agents.

  2014cites this paper
• From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer

  2014cites this paper
• Clathrin- and caveolae- independent endocytosis of newcastle disease virus strain AF2240 into hela cancer cell line

  2014cites this paper
• Mechanisms of oncolytic activity of Newcastle disease virus strain AF2240 in human renal carcinoma cell line

  2014cites this paper
• Viability Reduction and Rac1 Gene Downregulation of Heterogeneous Ex-Vivo Glioma Acute Slice Infected by the Oncolytic Newcastle Disease Virus Strain V4UPM

  2013cites this paper
• Dendritic Cells Pulsed with Viral Oncolysate

  2013cites this paper
• Experimental adenovirus gene therapy for cancer patients with advanced tumors : Translational medicine from basic research to the patient's bedside

  2013cites this paper
• Development and characterization of a recombinant vesicular stomatitis virus (rvsv) for the treatment of glioblastoma

  2013cites this paper
• Oncolytic Viruses As Therapeutic Agents For Prostate Cancer

  2013cites this paper
• Oncolytic Virotherapy Oncolytic virus therapy for cancer

  2013cites this paper
• The Oncolytic Activity of Newcastle Disease Virus in Clear Cell Renal Carcinoma Cells in Normoxic and Hypoxic Conditions: The Interplay Between von Hippel-Lindau and Interferon-β Signaling

  2013cites this paper